Wendy Campbell
Abstract
Fundamental changes to the capital gains tax treatment of non-resident investors are set to make foreign investment in Australian biotech companies more attractive.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Fundamental changes to the capital gains tax treatment of non-resident investors are set to make foreign investment in Australian biotech companies more attractive.
Key concepts: Project commissioning, Business, Publishing, Foreign direct investment, Investment (military), International trade, Economics, Political science